These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7197584)

  • 61. Bun-creatinine ratio in intraperitoneal extravasation of urine.
    Sullivan MJ; Banowsky LH; Lackner LH
    Surg Forum; 1972; 23(0):536-7. PubMed ID: 4671182
    [No Abstract]   [Full Text] [Related]  

  • 62. Utilization of a murine model to optimize volume and dwell time of intraperitoneal cisplatin.
    Pretorius RG; Eisenkop S; Berek JS; Hacker NF; Ashikaga T; Knox RM; Lagasse LD
    Gynecol Oncol; 1989 Jul; 34(1):66-9. PubMed ID: 2737529
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of a single therapeutic dose of cisplatin on GFR in dogs.
    Daniel G; Hahn K; Bravo L; Legendre A
    Oncol Rep; 1997; 4(1):153-6. PubMed ID: 21590032
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Increased tissue deposition and decreased excretion of platinum following administration of cisplatin to cisplatin-pretreated animals.
    Litterst CL; Schweitzer VG
    Cancer Chemother Pharmacol; 1984; 12(1):46-9. PubMed ID: 6537802
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Distribution of glass fibers in the peritoneal cavity of the rat following administration by intraperitoneal injection.
    Morgan A; Collier CG; Kellington JP
    J Toxicol Environ Health; 1993 Mar; 38(3):245-56. PubMed ID: 8450556
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hematologic changes associated with weekly low-dose cisplatin administration in dogs.
    Hahn KA; Rohrbach BW; Legendre AM; Frazier DL; Nolan ML
    Vet Clin Pathol; 1997; 26(1):29-31. PubMed ID: 12658611
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Route of administration-dependent anti-inflammatory effect of liposomal alendronate.
    Haber E; Afergan E; Epstein H; Gutman D; Koroukhov N; Ben-David M; Schachter M; Golomb G
    J Control Release; 2010 Dec; 148(2):226-33. PubMed ID: 20813142
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Laser microprobe mass spectrometry of platinum in dog kidney after cisplatin administration.
    Verbueken AH; Van Grieken RE; Paulus GJ; Verpooten GA; De Broe ME
    Biomed Mass Spectrom; 1984 Apr; 11(4):159-63. PubMed ID: 6539628
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Drug delivery systems for intraperitoneal therapy.
    Bajaj G; Yeo Y
    Pharm Res; 2010 May; 27(5):735-8. PubMed ID: 20198409
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of the Biological Behavior of a Gold Nanocore-Encapsulated Human Serum Albumin Nanoparticle (Au@HSANP) in a CT-26 Tumor/Ascites Mouse Model after Intravenous/Intraperitoneal Administration.
    Chen CC; Li JJ; Guo NH; Chang DY; Wang CY; Chen JT; Lin WJ; Chi KH; Lee YJ; Liu RS; Chen CL; Wang HE
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626093
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prolonged clearance of intraperitoneal 16 alpha-[125I]iodo-17 beta-estradiol in presence of ascites.
    Scharl A; Kullander S; Beckmann MW; Spicer JA; Baranczuk RJ; Holt JA
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 1):1847-53. PubMed ID: 1750485
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influence of insulin on pharmacokinetics of mannosulfan in rats.
    Danysz A; Wutkiewicz M; Wierzba K
    Arch Immunol Ther Exp (Warsz); 1979; 27(3):377-81. PubMed ID: 224835
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diagnosis of intraperitoneal extravasation of urine by peritoneal lavage.
    Rubin MJ; Blahd WH; Stanisic TH; Meislin HW
    Ann Emerg Med; 1985 May; 14(5):433-7. PubMed ID: 3985463
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Pharmacokinetics of non-protein bound platinum after intraperitoneal cisplatinum administration].
    Noda T; Hino K; Ninomiya Y; Kiyozuka Y; Katakami Y; Oku M; Saitoh S; Ichijo M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):147-9. PubMed ID: 3942396
    [No Abstract]   [Full Text] [Related]  

  • 75. Comparison of biopersistence of experimental glass fibres in the lung and peritoneal cavity.
    Morris KJ; Collier CG; Eastes W; Launder KA
    Exp Toxicol Pathol; 1996 Nov; 48(6):490-3. PubMed ID: 8954329
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preparation and metabolism of a cisplatin/serum protein complex.
    Cole WC; Wolf W
    Chem Biol Interact; 1980 May; 30(2):223-35. PubMed ID: 7190078
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model.
    Cvitkovic E; Spaulding J; Bethune V; Martin J; Whitmore WF
    Cancer; 1977 Apr; 39(4):1357-61. PubMed ID: 856436
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Modulatory effects of Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in mice.
    Nair SC; Salomi MJ; Panikkar B; Panikkar KR
    J Ethnopharmacol; 1991 Jan; 31(1):75-83. PubMed ID: 2030595
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Toxicity of aziridinylbenzoquinone administered Iv to beagle dogs.
    Hacker MP; Hong CB; McKee MJ; Unwin SE; Urbanek MA
    Cancer Treat Rep; 1982 Oct; 66(10):1845-51. PubMed ID: 7127322
    [No Abstract]   [Full Text] [Related]  

  • 80. [Comparison between blood levels, distribution in tissues and urinary elimination of desacetyl-lanatoside C labelled with tritium in the dog after intravenous and oral administration].
    Marchetti G; Riva D; Cerri O; Noseda V; Merlo L; Tallone G
    Minerva Med; 1967 Mar; 58(23):967-72. PubMed ID: 6023630
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.